[
    [
        {
            "time": "2023-03-15",
            "original_text": "Read This Before Buying Eli Lilly and Company (NYSE:LLY) For Its Upcoming $0.56 Dividend",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Dividend",
                    "Upcoming"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Read This Before Buying Eli Lilly and Company (NYSE:LLY) For Its Upcoming $0.56 Dividend",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Here's What Was Behind Nektar Therapeutics Stupendous 40% Jump in January",
            "features": {
                "keywords": [
                    "Nektar Therapeutics",
                    "Jump",
                    "January"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Here's What Was Behind Nektar Therapeutics Stupendous 40% Jump in January",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Array's Melanoma Combo Shows Positive Overall Survival Data",
            "features": {
                "keywords": [
                    "Array",
                    "Melanoma",
                    "Positive",
                    "Survival"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Array's Melanoma Combo Shows Positive Overall Survival Data",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]